and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might

Page 1 <img data-url='document/and-immunologydrraghunew-characterized-by-a-primary-or-secondary-deficit.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022042005/5e6fa72496c9e0651d683699/html5/thumbnails/1.jpg' width='140' height='200' /> Page 2 <img data-url='document/and-immunologydrraghunew-characterized-by-a-primary-or-secondary-deficit.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022042005/5e6fa72496c9e0651d683699/html5/thumbnails/2.jpg' width='140' height='200' /> Page 3 <img data-url='document/and-immunologydrraghunew-characterized-by-a-primary-or-secondary-deficit.html?page=3' data-page='3' class='cut-thumb lazyload' alt='Page 3: and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022042005/5e6fa72496c9e0651d683699/html5/thumbnails/3.jpg' width='140' height='200' /> Page 4 <img data-url='document/and-immunologydrraghunew-characterized-by-a-primary-or-secondary-deficit.html?page=4' data-page='4' class='cut-thumb lazyload' alt='Page 4: and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022042005/5e6fa72496c9e0651d683699/html5/thumbnails/4.jpg' width='140' height='200' />

and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might

Documents